XML 31 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock and Share-based Compensation Plans (Equity Instruments Other than Options) (Details) (USD $)
12 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares authorized 6,900,000    
Number of shares available for grant 5,300,000    
Restricted Stock [Member]
     
Shares [Roll Forward]      
Nonvested at beginning of year 576,000    
Granted, shares/units 179,000    
Vested, shares (146,000)    
Forfeited, shares (44,000)    
Nonvested at end of year 565,000 576,000  
Weighted Average Grant/Issue Date Fair Value [Roll Forward]      
Nonvested at beginning of year, weighted average grant/issue date fair value $ 30.96    
Granted, weighted average grant/issue date fair value $ 48.01    
Vested, weighted average grant/issue date fair value $ 31.79    
Forfeited, weighted average grant/issue date fair value $ 35.71    
Nonvested at end of year, weighted average grant/issue date fair value $ 35.77 $ 30.96  
Nonvested at end of year, aggregate intrinsic value $ 27,341,000    
Unearned compensation cost 6,000,000    
Unearned compensation cost, weighted average period of recognition (in years) 1 year 10 months    
Granted, weighted average grant date fair value $ 48.01 $ 34.69 $ 25.97
Total fair value of shares vested 6,200,000 5,600,000 900,000
Restricted Stock [Member] | Minimum [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Restricted Stock [Member] | Maximum [Member]
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 5 years    
Stock Equivalent Units [Member]
     
Shares [Roll Forward]      
Nonvested at beginning of year 201,000    
Granted, shares/units 42,000    
Converted to common stock, units (14,000)    
Nonvested at end of year 229,000 201,000  
Weighted Average Grant/Issue Date Fair Value [Roll Forward]      
Nonvested at beginning of year, weighted average grant/issue date fair value $ 35.60    
Granted, weighted average grant/issue date fair value $ 49.45    
Nonvested at end of year, weighted average grant/issue date fair value $ 38.19 $ 35.60  
Converted to common stock, total intrinsic value $ 100,000.0 $ 0 $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Converted in Period, Weighted Average Grant Date Fair Value $ 35.31